Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$235K Sell
3,993
-16
-0.4% -$1.01K 0.06% 117
2022
Q3
$229K Hold
4,009
0.05% 124
2022
Q2
$217K Hold
4,009
0.05% 119
2022
Q1
$230K Hold
4,009
0.04% 132
2021
Q4
$190K Hold
4,009
0.03% 142
2021
Q3
$169K Hold
4,009
0.03% 136
2021
Q2
$178K Hold
4,009
0.03% 142
2021
Q1
$187K Buy
+4,009
New +$177K 0.03% 132

Other funds holding CTVA

Burleson & Co's CTVA Position: Q4 2022 in Review

Burleson & Co reduced its Corteva (CTVA) stake by 0.4% in Q4 2022, selling an estimated $1.01K and leaving 3,993 shares worth $235K. The position accounts for 0.06% of the portfolio, ranked #117.

Burleson & Co first reported a position in CTVA in Q1 2021 and has held it in 8 quarters since. 1,302 funds tracked by Wall St. Rank hold CTVA as of Q4 2022.

  • Burleson & Co held 3,993 shares of Corteva worth $235K as of Q4 2022.
  • Burleson & Co sold 16 Corteva shares in Q4 2022, an estimated $1.01K.
  • Corteva made up 0.06% of Burleson & Co's portfolio in Q4 2022, its #117 holding.
  • Burleson & Co first reported a position in Corteva in Q1 2021 and has held it in 8 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Corteva as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.